
Loading, please wait...

Loading, please wait...

Gastrointestinal (GI) cancers impose a significant health burden globally, particularly affecting the population in India. Consequently, understanding the Galectin-3 GI cancer biomarker remains vital for improving diagnosis and patient outcomes. The LGALS3 gene encodes this multifunctional protein, which regulates cell adhesion and immune responses. Moreover, recent bioinformatic mapping reveals distinct expression patterns that influence tumor progression.
Specifically, the study indicates that LGALS3 shows significant upregulation in cholangiocarcinoma, esophageal adenocarcinoma, and liver hepatocellular carcinoma. Conversely, researchers observed downregulation in colon and rectal adenocarcinomas. These findings are important because high Galectin-3 levels often predict poorer survival rates, especially in liver and pancreatic cancers. In addition, the protein fosters an immunosuppressive tumor microenvironment. Therefore, clinicians can utilize this information to identify high-risk patients more accurately.
Protein-protein interaction analysis identifies MAPK3 and PTEN as key partners for Galectin-3. Furthermore, gene enrichment data highlights its involvement in T-cell activation and motility regulation. Thus, targeting this protein might enhance the efficacy of current immunotherapies by preventing tumor immune escape. In conclusion, Galectin-3 serves as both a diagnostic tool and a promising therapeutic target for advanced GI malignancies.
Galectin-3 serves as a significant prognostic indicator. High expression levels in liver and pancreatic cancers correlate with advanced disease stages and lower survival rates.
This protein contributes to an immunosuppressive microenvironment. It regulates T-cell activation and allows tumor cells to evade the body's natural defenses more effectively.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or a professional recommendation. Refer to the latest local and national guidelines for clinical practice.
References
Chiriva-Internati M et al. Galectin 3 expression in gastrointestinal tumors identified through comprehensive bioinformatic mapping. Discov Oncol. 2026 Jun 10. doi: 10.1007/s12672-026-04931-3. PMID: 42268362.
Song L, et al. Galectin-3 in cancer: Fondness and functions. J Hematol Oncol. 2014;7:77. doi: 10.1186/s13045-014-0077-0.
Scafetta G, et al. Galectin-3 and cancer immunotherapy: a glycobiological rationale to overcome tumor immune escape. J Exp Clin Cancer Res. 2024;43:41. doi: 10.1186/s13046-024-02968-2.

Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


A comprehensive bioinformatic mapping study has identified Galectin-3 (LGALS3) as a critical prognostic biomarker across seven gastrointestinal cancers. Elevated expression correlates with poor survival and an immunosuppressive environment, suggesting its potential as a targeted therapeutic option.
last month

Andhra Pradesh reported 10 new Covid-19 cases, taking the state tally to 49 while deaths remain at four. With 24 patients hospitalized and 16 under home isolation, the Health Department has intensified monitoring. Medical professionals should review regional distribution, diagnostic protocols, and management plans.
Today

An 11-year Swedish registry study of 618 uterine sarcoma patients found that minimally invasive surgery yielded survival comparable to open surgery in early stages. However, adjuvant chemotherapy conferred no survival benefit in localized or advanced disease, highlighting stage and histology as key outcomes.
3 days back

A cross-sectional study evaluates post-intensive care syndrome in cardiac patients 2-4 weeks post-ICU discharge, highlighting cognitive, psychological, and functional impairments and the need for structured multidisciplinary rehabilitation.
3 days back

Anterior cruciate ligament reconstruction failure lacks uniform definition. A narrative review proposes an integrative framework incorporating objective and subjective instability, persistent pain, restricted motion, graft rupture, and secondary meniscal injury to standardize clinical reporting.
3 days back

With World Obesity Atlas data warning that over 41 million Indian children are overweight or obese, ICMR and NIN have unveiled a 10-point policy roadmap. The initiative calls for mandatory front-of-pack labeling, HFSS taxes, strict marketing bans, and healthier school environments to curb non-communicable diseases.
Today